What are the ACOG guidelines for routine prenatal care and management in an uncomplicated pregnancy?

ACOG Guidelines for Routine Prenatal Care in Uncomplicated Pregnancy

The most recent ACOG guidance (2025) represents a transformative shift from the century-old prenatal care model, emphasizing tailored care delivery with flexible visit schedules, integration of telemedicine, and addressing social determinants of health, while maintaining core screening and educational components 1.

Core Components of Prenatal Care

Visit Schedule and Frequency

The traditional prenatal visit schedule established in 1930 (monthly until 28 weeks, biweekly until 36 weeks, then weekly) has remained largely unchanged in ACOG guidelines through 2017 2. However, ACOG's 2025 Clinical Consensus now supports flexible, risk-based visit schedules rather than rigid adherence to the historical 13-14 visit model 1.

For low-risk pregnancies:

• First trimester: Initial visit by 10 weeks, with 4-week intervals
• Second trimester: 2-4 week intervals (28-32 weeks)
• Third trimester: 1-2 week intervals after 36 weeks
• Total visits: Can be tailored based on individual needs rather than the traditional 13-14 visits

This represents a significant departure from previous rigid scheduling, with evidence from international guidelines showing that countries like France and the Netherlands successfully use 7.5 visits for low-risk women 3.

Essential Screening and Laboratory Tests

All pregnant women should receive 4, 5:

Initial visit screening:

• Complete blood count (anemia screening)
• Blood type and Rh status
• Antibody screen
• Urinalysis and urine culture
• Syphilis screening
• HIV testing
• Hepatitis B surface antigen
• Rubella immunity status
• Gonorrhea and chlamydia screening (as indicated)
• Cervical cytology (if due)
• Thyroid-stimulating hormone (consider, especially if symptomatic)

Ongoing assessments at each visit:

• Blood pressure measurement (pre-eclampsia screening)
• Urine protein assessment
• Fundal height measurement
• Fetal heart rate assessment
• Fetal movement assessment (after 28-30 weeks)
• Fetal presentation (at/after 36 weeks)

Gestational age-specific screening:

• First trimester (11-14 weeks): Optional aneuploidy screening with nuchal translucency and biochemical markers 6
• 15-20 weeks: Maternal serum alpha-fetoprotein or quad screen
• 24-28 weeks: Glucose tolerance testing for gestational diabetes
• 35-37 weeks: Group B streptococcus screening

Clinical Interventions and Supplementation

Universal recommendations 4, 7, 5:

• Folic acid: 400-800 mcg daily for all women of reproductive age; 4 mg daily for those at high risk of neural tube defects (prior affected pregnancy, antiepileptic medications)
• Iron supplementation: Recommended in most guidelines (10/15 routine ANC guidelines) 5
• Prenatal vitamins: Containing essential micronutrients
• Aspirin prophylaxis: 81-150 mg daily starting before 16 weeks for women with risk factors for preeclampsia (prior preeclampsia, chronic hypertension, pregestational diabetes, BMI >30, chronic kidney disease, antiphospholipid syndrome, or ≥2 minor risk factors) 8
• Calcium supplementation: 1200 mg daily if dietary calcium intake is low 8

Immunizations

Review and update immunization status annually 4:

• Tdap vaccine (ideally 27-36 weeks each pregnancy)
• Influenza vaccine (any trimester during flu season)
• COVID-19 vaccination (as recommended)
• Ensure immunity to rubella and varicella before pregnancy
• Hepatitis B series if not immune
• Avoid live vaccines during pregnancy

Risk Assessment and Referral Criteria

Early pregnancy risk assessment should identify 9:

High-risk factors requiring specialist referral before 20 weeks:

• Previous pre-eclampsia
• Multiple pregnancy
• Pre-existing hypertension (diastolic BP ≥90 mmHg)
• Pre-existing renal disease or significant proteinuria
• Pre-existing diabetes
• Antiphospholipid antibodies
• Any two moderate risk factors

Moderate risk factors:

• First pregnancy (nulliparity)
• Age ≥40 years
• BMI ≥35
• Family history of pre-eclampsia
• Booking diastolic BP ≥80 mmHg
• Pregnancy interval ≥10 years

Education and Counseling

Essential educational topics 4, 5, 7, 5, 3:

• Nutrition: Balanced diet, food safety, weight gain expectations, folate-rich foods
• Physical activity: Safe exercise recommendations, appropriate rest
• Substance use: Tobacco cessation, alcohol avoidance, illicit drug cessation
• Medications: Review all medications, avoid teratogens (Category X drugs, most Category D drugs)
• Breastfeeding: Benefits and preparation (recommended in 9/15 routine ANC guidelines) 5
• Labor and delivery preparation: Signs of labor, when to call, birth plan discussion
• Postpartum planning: Contraception, postpartum warning signs
• Infant care: Safe sleep practices, car seat safety

Psychosocial Screening and Support

Universal screening recommended 4, 7, 3:

• Depression and anxiety: Screen at initial visit and periodically throughout pregnancy
• Intimate partner violence: Screen at each trimester
• Substance abuse: Use validated tools (CAGE, T-ACE questionnaires)
• Social determinants of health: Housing insecurity, food insecurity, transportation barriers
• Social support: Assess available support systems

Management: Refer to appropriate resources when needs identified; consider mental health treatment individualized to pregnancy 4.

Chronic Disease Management

For women with pre-existing conditions 4:

• Hypertension: Counsel on lifestyle modifications and pregnancy-safe antihypertensives
• Diabetes: Emphasize importance of glycemic control (target HbA1c <6-6.5% preconception)
• Thyroid disease: Optimize thyroid function before and during pregnancy
• Asthma: Continue appropriate controller medications
• Mental health disorders: Adjust medications to pregnancy-safe options when possible; weigh risks of untreated illness

Alternative Care Delivery Models

ACOG now recognizes multiple valid approaches 10, 11, 1:

• Group prenatal care: May improve patient education, satisfaction, breastfeeding initiation, and prenatal knowledge without causing harm
• Telemedicine: Can be integrated for appropriate visits, particularly for low-risk patients
• Midwife or general practitioner-led care: Appropriate for low-risk pregnancies (recommended in 6/9 peer countries) 3
• Continuity of care: Beneficial when feasible

Key Implementation Points

Common pitfalls to avoid:

1. Rigid adherence to outdated visit schedules: The 2025 ACOG guidance supports flexibility based on individual needs 1
2. Missing early risk assessment: Failure to identify high-risk patients before 20 weeks delays appropriate specialist referral 9
3. Inadequate aspirin prophylaxis: Must start before 16 weeks to be effective for preeclampsia prevention 8
4. Insufficient psychosocial screening: Depression, anxiety, and intimate partner violence screening often overlooked
5. Poor documentation: Studies show incomplete recording of maternal height, fetal activity after 30 weeks, and fetal presentation after 36 weeks 12

Strength of evidence: The 2025 ACOG Clinical Consensus 1 represents the most current guidance, though it acknowledges that prenatal care models require ongoing study. The traditional visit schedule lacks strong evidence for its specific frequency, with international data showing successful outcomes with fewer visits 3. Core screening interventions (syphilis, HIV, anemia, blood pressure, proteinuria) have the strongest evidence base across all guidelines 5.

Provider adherence: Historical data shows that when guidelines are appropriately disseminated, providers across specialties and geographic locations can adhere closely to detailed clinical guidelines, with certified nurse-midwives showing particularly high adherence rates 12.